Protalix BioTherapeutics Inc. Annual stock financials by MarketWatch. View the latest PLX financial statements, income statements and financial ratios.
Hosted on MSN
Good Day Atlanta viewer information: Oct. 28, 2025
Atlanta - Here are the guests and segments from Good Day Atlanta on Oct. 28, 2025: Chef Kevin Rathbun "fires up" a passion for pizza: We’re just days away from Halloween — but October 31st also marks ...
Machinify has closed its roughly $670 million acquisition of Performant Healthcare. In August, the Dallas-based health care payments company backed by a New York private equity firm entered into a ...
The recent news of Qualcomm acquiring Arduino has stirred both excitement and unease in the maker and open-source hardware communities. Reports suggest that Arduino will retain its brand, tools, and ...
When a CEO wants to boost corporate performance or jump-start long-term growth, the thought of acquiring another company can be extraordinarily seductive. Indeed, companies spend more than $2 trillion ...
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback